• European Prostate Cancer Awareness Day 22 January 2019

Prostate Cancer Screening: early diagnosis and improving outcomes

The European Prostate Cancer Awareness Day (EPAD) aims to raise awareness, understanding, and knowledge of the management of prostate cancer. Political and scientific influencers will gather for this biannual event in the European Parliament on 22 January 2019.

 

Taking steps in improving Prostate Cancer Care

Prostate Cancer is on the rise and the most frequent cancer in men. In fact, it is the third most common cause of cancer death in men in Europe, with important consequences for healthcare systems. Saving lives and ensuring a high quality of life requires immediate European actions.

The incidence of advanced Prostate Cancer in some countries is likely a reflection of the late detection. The lack of awareness of the need for early detection and in some cases the lack of proper diagnostic tools lead to (too) late discovery of the disease.

It is well-known that Prostate Specific Antigen (PSA) tests in population screening programmes reduce the prostate cancer mortality rate. Still, the discussion on over-diagnosis and overtreatment continues while there are already new developments available that make better use of PSA testing and more to come.

To rediscuss prostate cancer screening with the political decision-makers in Europe, the European Association of Urology (EAU) and its partners organise a European Prostate Cancer Awareness Day (EPAD) on 22 January 2019. Policy makers, scientific experts, European associations working in the urological field and representatives of European patient groups with an interest in prostate disease will come together in the European Parliament.

Following a Policy Paper on population-based PSA screening for prostate cancer, the event will consider and discuss how early diagnosis will improve outcomes in European PCa patients, presenting new evidence and analysis to support a cleverer and targeted approach of PSA testing.

The meeting will be hosted by Mr Alojz Peterle, President of the “MEPs against Cancer” group (MAC) and EU Commissioner Vytenis Andriukaitis will reflect on this matter from the perspective of the European Commission.

We look forward to welcoming you in Brussels on 22 January to jointly improve mortality rate in prostate cancer!

 

Share the European Prostate Cancer Awareness Day with your friends and colleagues:

 

 

Prostate Cancer in Europe

Prevalence

 

More than two million European men are living with prostate cancer.

Mortality

 

Each year, over 92,000 men in the European Member States die of prostate cancer.

Costs

 

The yearly costs of PCa in Europe are over 9 billion euros, with healthcare accounting for 5.8 billion euros.